ofa semaglutide Higher dose of increases weight loss, metabolic benefits: Newsroom The FDA Has Approved An

Semaglutide has approvals for reducing cardiovascular risks in patients with heart disease, protecting kidney function in those with chronic kidney disease, and treating metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis

Consumers should verify the current checkout total, plan length, medication track, dose, subscription terms, and billing cycle directly with Gala before entering payment information - plan terms and promotional pricing can change

Mounjaro is only approved to help improve blood sugar levels in adults with type-2 diabetes, but licensed healthcare providers can prescribe it off-label for weight loss

BCBS Companies and Licensees